These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 7526222)

  • 1. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.
    Araki E; Lipes MA; Patti ME; Brüning JC; Haag B; Johnson RS; Kahn CR
    Nature; 1994 Nov; 372(6502):186-90. PubMed ID: 7526222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.
    Tamemoto H; Kadowaki T; Tobe K; Yagi T; Sakura H; Hayakawa T; Terauchi Y; Ueki K; Kaburagi Y; Satoh S
    Nature; 1994 Nov; 372(6502):182-6. PubMed ID: 7969452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and IGF-I signaling through the insulin receptor substrate 1.
    Keller SR; Lamphere L; Lavan BE; Kuhné MR; Lienhard GE
    Mol Reprod Dev; 1993 Aug; 35(4):346-51; discussion 351-2. PubMed ID: 8398112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the actin network in insulin signalling.
    Tsakiridis T; Wang Q; Taha C; Grinstein S; Downey G; Klip A
    Soc Gen Physiol Ser; 1997; 52():257-71. PubMed ID: 9210235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling.
    Minami K; Morita M; Saraya A; Yano H; Terauchi Y; Miki T; Kuriyama T; Kadowaki T; Seino S
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1289-96. PubMed ID: 12933351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IRS-2 in insulin and cytokine signalling.
    Sun XJ; Wang LM; Zhang Y; Yenush L; Myers MG; Glasheen E; Lane WS; Pierce JH; White MF
    Nature; 1995 Sep; 377(6545):173-7. PubMed ID: 7675087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IRS-signalling system in insulin and cytokine action.
    White MF
    Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):181-9. PubMed ID: 8650265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol impairs insulin receptor substrate-1 mediated signal transduction during rat liver regeneration.
    Sasaki Y; Wands JR
    Biochem Biophys Res Commun; 1994 Feb; 199(1):403-9. PubMed ID: 7510107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.
    Sun XJ; Rothenberg P; Kahn CR; Backer JM; Araki E; Wilden PA; Cahill DA; Goldstein BJ; White MF
    Nature; 1991 Jul; 352(6330):73-7. PubMed ID: 1648180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
    Myers MG; Sun XJ; Cheatham B; Jachna BR; Glasheen EM; Backer JM; White MF
    Endocrinology; 1993 Apr; 132(4):1421-30. PubMed ID: 8384986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
    Brüning JC; Winnay J; Cheatham B; Kahn CR
    Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.
    Folli F; Saad MJ; Backer JM; Kahn CR
    J Clin Invest; 1993 Oct; 92(4):1787-94. PubMed ID: 7691886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase.
    Rocchi S; Tartare-Deckert S; Mothe I; Van Obberghen E
    Endocrinology; 1995 Dec; 136(12):5291-7. PubMed ID: 7588273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family.
    Kaburagi Y; Yamauchi T; Yamamoto-Honda R; Ueki K; Tobe K; Akanuma Y; Yazaki Y; Kadowaki T
    Endocr J; 1999 Mar; 46(Suppl):S25-34. PubMed ID: 12054114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.
    Patti ME; Sun XJ; Bruening JC; Araki E; Lipes MA; White MF; Kahn CR
    J Biol Chem; 1995 Oct; 270(42):24670-3. PubMed ID: 7559579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.
    Giorgino F; Smith RJ
    J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signaling after exercise in insulin receptor substrate-2-deficient mice.
    Howlett KF; Sakamoto K; Hirshman MF; Aschenbach WG; Dow M; White MF; Goodyear LJ
    Diabetes; 2002 Feb; 51(2):479-83. PubMed ID: 11812758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.